Dicerna Pharmaceuticals Market Cap 2012-2021 | DRNA
Dicerna Pharmaceuticals market cap history and chart from 2012 to 2021. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Dicerna Pharmaceuticals market cap as of November 29, 2021 is $2.97B.
||Medical - Biomedical and Genetics
Dicerna Pharmaceuticals, Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The company uses its proprietary RNA interference technology platform primarily in the United States and internationally. Dicerna Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.